IMS Health Inc.
901 Main Avenue
Suite 612
Norwalk,
CT 06851
United States - Map
Phone: 203-845-5200
Fax: 203-845-5299
Web Site: http://www.imshealth.com
| IMS Health Incorporated provides business intelligence, including information, analytics, and consulting services to the pharmaceutical and healthcare industries worldwide. The company offers sales territory reporting, prescription tracking reporting, and sales and account management; pharmaceutical audits, medical audits, prescription audits, hospital audits, and published audit reports, as well as analysis of anonymized prescription and/or medical records. It also provides MIDAS, an online multinational integrated data analysis tool to assess and analyze global pharmaceutical information and trends in multiple markets; other portfolio optimization reports; and promotional audits and promotion management consulting, pricing and market access consulting, oncology analyzer and consulting, and forecasting portfolio services. In addition, IMS Health offers products and services, including information to know the effects of managed markets on the pharmaceutical and healthcare industries; information of product movement, market share, and pricing in the consumer health area; and consulting and services, such as evidence-based solutions that allow its clients to make informed business decisions. The company was founded in 1954 and is based in Norwalk, Connecticut. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. David R. Carlucci , 54
Exec. Chairman, Chief Exec. Officer and Pres |
N/A
| N/A | Ms. Leslye G. Katz , 54
Chief Financial Officer and Sr. VP |
$
505.00K |
$
87.00K | Mr. Gilles V. J. Pajot , 59
Chief Operating Officer |
$
1.09M |
$
403.00K | Mr. Robert H. Steinfeld , 55
Sr. VP, Corp. Sec. and Gen. Counsel |
$
539.00K |
$
246.00K | Mr. Kevin C. Knightly , 48
Sr. VP of Bus. Line Management |
$
669.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.23% Nasdaq 
Profile
